News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioCorp Winner Of The 2017 E-Health Trophies Thanks To Its Intelligent Sensor Inspair



7/18/2017 11:01:38 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
ISSOIRE, France - ( BUSINESS WIRE ) - Regulatory News:

BIOCORP (Paris: ALCOR) (FR0012788065 - ALCOR / eligible PEA-PME), a French company specializing in the development and manufacture of innovative medical devices and drug delivery systems, -Health 2017 in the category "Connected Health Objects" with its Intelligent Sensor Inspair. The event took place during the 11 th edition of the Summer University of e-Health 1 from 4 to 6 July 2017.

Organized by the European Center for Enterprise and Innovation Castres Mazamet Technopole, the Summer School of e-Health, is the inevitable meeting place for healthcare professionals and industrial solutions providers, researchers and networks Of patients. This eleventh edition brought together more than 800 participants, actors and decision-makers from the health and social sector and technological innovation, to discuss the uses of ICT 2 in the field of health and well-being

The international competition, which received more than 118 applications this year, distinguished the winners on 8 categories and 3 special prizes. Thanks to its Inspair sensor, BIOCORP was awarded the "Connected Health Objects" category, supported by Harmonie Mutuelle, a partner of this edition for the promotion and development of new connected solutions. Inspair is an intelligent sensor that transforms any conventional aerosol-meter inhaler into a connected and communicating device. It automatically records inhalations performed by the patient, checks for proper hand-to-hand coordination to ensure optimal use of the device, And transmits the data to a mobile processing management application that facilitates the patient's life. Indicated in the context of chronic respiratory diseases such as asthma or COPD (Chronic Obstructive Pulmonary Disease), this innovative device contributes to the observance of the treatment and also optimizes the therapeutic follow-up of the patient.

" We are very proud to receive this award from the Summer University of e-Health, which represents a new validation of the innovation process put forward by BIOCORP. We are guided by a strong commitment in favor of patients and pharmaceutical players, and this trophy underlines once again our ability to develop devices that are both innovative and simple to implement and that meet a real therapeutic need ", comments Eric Dessertenne , Deputy Managing Director of BIOCORP.

ABOUT BIOCORP

Created in 2004 in Issoire (near Clermont-Ferrand), BIOCORP is a French company, labeled BPI 'Innovative company' and specialized in the development and manufacture of medical devices and innovative drug delivery systems. With more than twenty years of experience, more than 30M units produced each year and 12 patent families, BIOCORP is a recognized actor in the sector at the heart of the evolution of the delivery systems with solutions that meet the new needs of patients. Today, BIOCORP continues to innovate on medical plastics, its original business, to produce and market traditional devices (alternatives to the aluminum capsule, Syringe-replenishing systems) generating a recurring turnover. His strong expertise and innovation capabilities have also enabled him to develop a range of connected products, including the DataPen, a reusable and communicating pen-injector, linked to a mobile application, and add-ons, Existing delivery devices and compatible with most market-leading pens such as Easylog, the first add-on that transforms insulin delivery devices into connected devices. The company has 48 employees.

BIOCORP has been listed on Euronext Growth Paris since July 2015 (FR0012788065 - ALCOR). For more information: www.biocorp.

1 http://www.universite-esante.com/

2 Information and communication technologies

contacts
BIOCORP
Jacques Gardette
Chairman and Chief Executive Officer
investors@biocorp.fr

or

Eric Dessertenne
Deputy Chief Executive Officer

or

Press Relations
ALIZE RP
Caroline Carmagnol & Wendy Rigal
01 44 54 36 66 - 06 48 82 18 94
biocorp@alizerp.com


Read at BioSpace.com


comments powered by Disqus
BioCorp
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES